Iressa Case Control Study in Japan
The purposes of this study are:

* To estimate the relative risk of ILD in advanced/recurrence NSCLC patients treated with gefitinib as compared to other chemotherapy treatment, and to assess the risk factors for ILD in advanced/recurrence NSCLC patients undergoing treatment
* To provide an estimate of the incidence of ILD in a group of advanced/recurrence NSCLC patients undergoing treatment
Non-small Cell Lung Cancer
The purposes of this study are:

* To estimate the relative risk of ILD in advanced/recurrence NSCLC patients treated with gefitinib as compared to other chemotherapy treatment, and to assess the risk factors for ILD in advanced/recurrence NSCLC patients undergoing treatment
* To provide an estimate of the incidence of ILD in a group of advanced/recurrence NSCLC patients undergoing treatment